These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15455263)

  • 1. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
    Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
    Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
    Martin ER; Lai EH; Gilbert JR; Rogala AR; Afshari AJ; Riley J; Finch KL; Stevens JF; Livak KJ; Slotterbeck BD; Slifer SH; Warren LL; Conneally PM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
    Am J Hum Genet; 2000 Aug; 67(2):383-94. PubMed ID: 10869235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE and APOC1 promoter polymorphisms and the risk of Alzheimer disease in African American and Caribbean Hispanic individuals.
    Tycko B; Lee JH; Ciappa A; Saxena A; Li CM; Feng L; Arriaga A; Stern Y; Lantigua R; Shachter N; Mayeux R
    Arch Neurol; 2004 Sep; 61(9):1434-9. PubMed ID: 15364690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
    Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
    Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
    Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
    Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.
    Beyer K; Lao JI; Gómez M; Riutort N; Latorre P; Mate JL; Ariza A
    Neurosci Lett; 2002 Jul; 326(3):187-90. PubMed ID: 12095653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.
    Chartier-Harlin MC; Parfitt M; Legrain S; Pérez-Tur J; Brousseau T; Evans A; Berr C; Vidal O; Roques P; Gourlet V
    Hum Mol Genet; 1994 Apr; 3(4):569-74. PubMed ID: 8069300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease.
    Capurso C; Panza F; Seripa D; Frisardi V; Imbimbo BP; Verdile G; Vendemiale G; Pilotto A; Solfrizzi V
    Rejuvenation Res; 2010 Dec; 13(6):645-52. PubMed ID: 20818931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease.
    Bahia VS; Kok F; Marie SN; Shinjo SO; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2008; 22(1):61-5. PubMed ID: 18317248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
    Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
    Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY; Ding JQ; Chen SD
    J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association Between Clusterin and APOE Polymorphisms and Late-Onset Alzheimer Disease in a Turkish Cohort.
    Alaylıoğlu M; Gezen-Ak D; Dursun E; Bilgiç B; Hanağası H; Ertan T; Gürvit H; Emre M; Eker E; Uysal Ö; Yılmazer S
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):221-6. PubMed ID: 27076484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.